Spinal Anesthesia of a Patient with Central Core Disease for Caesarean Section: A Case Report

Authors

  • Se Jin Kim Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Chuncheon, South Korea
  • Yeon Ji Roh Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Chuncheon, South Korea
  • So Yeon Cho Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Chuncheon, South Korea
  • Jangho Bae Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Chuncheon, South Korea
  • Seongsik Kang Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Chuncheon, South Korea

DOI:

https://doi.org/10.24203/ajpnms.v9i3.6610

Keywords:

Central core disease, Congenital myopathy, General anesthesia, Malignant hyperthermia, Spinal anesthesia

Abstract

Central core disease is an autosomal dominant congenital myopathy. It typically manifests as muscle weakness and developmental delay. Central core disease is also associated with malignant hyperthermia which can be developed by volatile agent or succinylcholine. Here, we are reporting a case of a 34-year-old primigravida with central core disease who underwent an emergency cesarean section under spinal anesthesia without complications.

 

References

Shy GM, Magee KR. A new congenital non-progressive myopathy. Brain 1956; 79: 610–2.

Ronald D. Miller. Miller`s anesthesia 8th edition Volume 1 1130

Denborough MA, Dennet X, Anderson RM. Central-core disease and malignant hyperpyrexia. British Medical Journal 1973; 1: 272–3.

Treves S, Jungbluth H, Muntoni F, Zorzato F. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol 2008; 8: 319–26

A K Brownell, R T Paasuke. Use of local anesthetics in malignant hyperthermia. CMAJ. 1986 May 1; 134(9): 993–994.

A J McKenzie, K G Couchman, N Pollock. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. Anaesth Intensive Care. 1992 May;20(2):165-8. doi: 10.1177/0310057X9202000208

Liguo HuJianhui, PanShantang, ZhangJinjing, YuKeqiang, HeShuhua, ShuRuiting Wang. Propofol in combination with remifentanil for cesarean section:Placental transfer and effect on mothers and newborns at differentinduction to delivery intervals. Taiwanese Journal of Obstetrics and Gynecology Volume 56, Issue 4, August 2017, Pages 521-526

A.P. Georgiou, J. Gatward. Emergency anaesthesia in central core disease. BJA CORRESPONDENCE VOLUME 100, ISSUE 4, P567, APRIL 01, 2008

Downloads

Published

2021-07-02

How to Cite

Kim , S. J. ., Roh, . Y. J. ., Cho , S. Y., Bae, J., & Kang, S. (2021). Spinal Anesthesia of a Patient with Central Core Disease for Caesarean Section: A Case Report. Asian Journal of Pharmacy, Nursing and Medical Sciences, 9(3). https://doi.org/10.24203/ajpnms.v9i3.6610

Issue

Section

Articles